Julianna Lisziewicz Selected Research

Didanosine (Videx)

7/2005	Optimal suppression of HIV replication by low-dose hydroxyurea through the combination of antiviral and cytostatic ('virostatic') mechanisms.
2/2004	Strategies to decrease viral load rebound, and prevent loss of CD4 and onset of resistance during structured treatment interruptions.
1/2004	T-cell receptor excision circles (TREC) in SHIV 89.6p and SIVmac251 models of HIV-1 infection.
1/2003	Hydroxyurea in the treatment of HIV infection: clinical efficacy and safety concerns.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julianna Lisziewicz Research Topics

Disease

8	Infections 01/2014 - 02/2002
6	Acquired Immunodeficiency Syndrome (AIDS) 01/2013 - 02/2002
6	HIV Infections (HIV Infection) 01/2006 - 03/2002
4	Sexually Transmitted Diseases (Sexually Transmitted Disease) 02/2004 - 02/2002
2	Viremia 01/2014 - 03/2002
2	Vaccinia 09/2008 - 05/2003
2	Pancreatitis 07/2005 - 01/2003
2	Persistent Infection 01/2005 - 02/2002
1	West Nile Fever 01/2014
1	Communicable Diseases (Infectious Diseases) 01/2014
1	Allergic Rhinitis 11/2013
1	Hypersensitivity (Allergy) 11/2013
1	Flushing 01/2013
1	Erythema 01/2006

Drug/Important Bio-Agent (IBA)

7	DermaVirIBA 01/2013 - 01/2005
4	VaccinesIBA 01/2014 - 01/2004
4	Pharmaceutical PreparationsIBA 01/2013 - 03/2002
4	Hydroxyurea (Hydrea)FDA LinkGeneric 07/2005 - 01/2003
4	Didanosine (Videx)FDA LinkGeneric 07/2005 - 01/2003
2	Antiviral Agents (Antivirals)IBA 01/2014 - 07/2005
2	DNA VaccinesIBA 01/2014 - 01/2006
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 09/2007
2	Stavudine (Zerit)FDA LinkGeneric 02/2004 - 01/2003
1	Mannose (D-Mannose)IBA 01/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2014
1	PolyethyleneimineIBA 01/2014
1	Immunoglobulin E (IgE)IBA 11/2013
1	OvalbuminIBA 11/2013
1	AllergensIBA 11/2013
1	Anti-Infective Agents (Microbicides)IBA 01/2013
1	Interleukin-15 (Interleukin 15)IBA 09/2008
1	Viral DNAIBA 01/2006
1	Cytostatic AgentsIBA 07/2005
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2004
1	Indinavir (Crixivan)FDA Link 02/2004
1	Peptide Hydrolases (Proteases)FDA Link 02/2004
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2004
1	Biomarkers (Surrogate Marker)IBA 01/2004
1	AntigensIBA 05/2003
1	Peptides (Polypeptides)IBA 05/2003
1	HLA-DR Antigens (HLA-DR)IBA 05/2003

Therapy/Procedure

7	Therapeutics 01/2006 - 02/2002
3	Highly Active Antiretroviral Therapy (HAART) 02/2004 - 03/2002
1	Duration of Therapy 11/2013
1	Immunotherapy 11/2013
1	Salvage Therapy 08/2002